Review

Diabetes and Alzheimer's Disease - Is There a Connection?

Anders A.F. Sima^1,2, Zhen-guo Li¹

Keywords: diabetes, Alzheimer's disease, insulin, hypercholesterolemia, dementia

Abstract

It has been known for some time that diabetes may be associated with impaired cognitive function. During the last decade, epidemiological data have emerged suggesting a linkage between diabetes, particularly type 2 diabetes, and Alzheimer's disease (AD). There is evidence to suggest that impaired activities of neurotrophic factors such as insulin, IGF-1 and NGF, which occur in both diabetes and AD, may provide a mechanistic link between the two disorders. An additional probable factor that has been less evaluated to date is hypercholesterolemia, a common accompaniment to type 2 diabetes. Increased cholesterol availability is believed to play a crucial role in the abnormal metabolism of amyloid precursor protein leading to accumulation of amyloid-β. Impaired insulin signaling in particular appears to be involved in hyperphosphorylation of the tau protein, which constitutes neurofibrillary tangles in AD. The linkage between abnormal amyloid metabolism and phosphor-tau is likely to be provided by the activation of caspases both by increased amyloid-β and by impaired insulin signaling. Although the details of many of these components still await evaluation, it appears clear that commonalities exist in the underlying pathogenesis of diabetes and Alzheimer’s disease. In this review we provide a brief update on linkages between these two diverse but common disorders.

Fulltext: HTML , PDF (513KB)

This article has been cited by other articles:

	Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E Exp Neurol 2010. 223(2):422-431
	Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide Sima AA, Zhang W, Muzik O, Kreipke CW, Rafols JA, Hoffman WH Rev Diabet Stud 2009. 6(3):211-222
	Effects of stress and stress hormones on amyloid-\beta protein and plaque deposition Dong H, Csernansky JG J Alzheimers Dis 2009. 18(2):459-469
	Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer’s disease and correction by insulin Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA, Masliah E J Neurosci Res 2008. 86(15):3265-3274
	Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes? Sima AA, Kamiya H Curr Drug Targets 2008. 9(1):37-46
	Vanadyl bisacetylacetonate induced G1/S cell cycle arrest via high-intensity ERK phosphorylation in HepG2 cells Fu Y, Wang Q, Yang XG, Yang XD, Wang K J Biol Inorg Chem 2008. 13(6):1001-1009